journal article·2018-02-07

Nanostructured Peptidotoxins as Natural Pro-Oxidants Induced Cancer Cell Death via Amplification of Oxidative Stress

Hongzhi Qiao, Dong Fang, Lei Zhang, Xiaochen Gu, Yin Lu, Minjie Sun, Chunmeng Sun, Qineng Ping, Junsong Li, Zhipeng Chen, Jun Chen, Lihong Hu, Liuqing Di

Publisher page

Abstract

Melittin (Mel), one of the host defense peptides derived from the venom of honeybees, demonstrates substantial anticancer properties, which is attributed to augmenting reactive oxygen species (ROS) generation. However, little has been reported on its pro-oxidation capacity in cancer oxidation therapy. In this study, an ROS amplifying nanodevice was fabricated through direct complexation of two natural pro-oxidants, Mel and condensed epigallocatechin gallate (pEGCG). The obtained nanocomplex (NC) was further covered with phenylboronic acid derivatized hyaluronic acid (pHA) through the ROS-responsive boronate ester coordination bond to produce pHA-NC. Upon undergoing receptor-mediated endocytosis into cancer cells, the inner cores of pHA-NC will be partially uncovered once pHA corona is degraded by hyaluronidase and will then escape from the lysosome by virtue of cytolytic Mel. The elevated ROS level in the tumor cytoplasm can disrupt the boronate ester bond to facilitate drug release. Both Mel and pEGCG could synergistically amplify oxidative stress and prolong ROS retention in cancer cells, leading to enhanced anticancer efficacy. This ROS cascade amplifier based on selective coordination bond and inherent pro-oxidation properties of natural ingredients could detect and elevate intracellular ROS signals, potentiating to move the tumor away from its homeostasis and make the tumor vulnerable. Compared to previously reported chemosynthetic pro-oxidants, the ROS self-sufficient system, fully composed of natural medicine, from this study provides a new insight in developing cancer oxidation therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Antimicrobial Peptides and Activities · Healthcare and Venom Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmacy, University of Manitoba, 750 McDermot Avenue, Winnipeg, Manitoba R3E 0T5, Canada

State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China

Funding

China Association for Science and Technology · Natural Science Foundation of Jiangsu Province · National Natural Science Foundation of China · Outstanding Scientific and Technological Innovation Team of Jiangsu Higher Education Institutions · Jiangsu Province · Priority Academic Program Development of Jiangsu Higher Education Institutions

References (58)

Show source-provided references
1. 10.1038/nrd359110.1038/nrd3591 ↗
2. 10.1038/nri.2016.2910.1038/nri.2016.29 ↗
3. 10.1016/j.etap.2013.06.00910.1016/j.etap.2013.06.009 ↗
4. 10.3748/wjg.v22.i11.318610.3748/wjg.v22.i11.3186 ↗
5. 10.1021/np300446c10.1021/np300446c ↗
6. 10.1073/pnas.130701011010.1073/pnas.1307010110 ↗
7. 10.1021/nn400683s10.1021/nn400683s ↗
8. 10.1016/j.jconrel.2011.08.02910.1016/j.jconrel.2011.08.029 ↗
9. 10.1002/bab.5710.1002/bab.57 ↗
10. 10.1021/nl073290r10.1021/nl073290r ↗
11. 10.1016/j.bcp.2011.07.09310.1016/j.bcp.2011.07.093 ↗
12. 10.1021/jacs.7b0501210.1021/jacs.7b05012 ↗
13. 10.1021/acsami.6b0685310.1021/acsami.6b06853 ↗
14. 10.1073/pnas.141770311210.1073/pnas.1417703112 ↗
15. 10.1158/1078-0432.ccr-04-227310.1158/1078-0432.ccr-04-2273 ↗
16. 10.1038/nchembio.60710.1038/nchembio.607 ↗
17. 10.1039/c6cs00271d10.1039/c6cs00271d ↗
18. 10.1002/adma.20170014110.1002/adma.201700141 ↗
19. 10.1021/acs.nanolett.7b0353110.1021/acs.nanolett.7b03531 ↗
20. 10.1002/anie.20120963310.1002/anie.201209633 ↗
21. 10.1038/ncomms790710.1038/ncomms7907 ↗
22. 10.1016/j.biomaterials.2013.01.03710.1016/j.biomaterials.2013.01.037 ↗
23. 10.1021/bm034243610.1021/bm0342436 ↗
24. 10.1038/ncomms109310.1038/ncomms1093 ↗
25. 10.1021/nn301383810.1021/nn3013838 ↗
26. 10.1039/c5an00850f10.1039/c5an00850f ↗
27. 10.1016/j.actbio.2017.02.03010.1016/j.actbio.2017.02.030 ↗
28. 10.1021/ja203077x10.1021/ja203077x ↗
29. 10.1021/acsami.5b0498710.1021/acsami.5b04987 ↗
30. 10.1021/bm400121q10.1021/bm400121q ↗
31. 10.1016/j.jpba.2015.01.01810.1016/j.jpba.2015.01.018 ↗
32. 10.1016/j.biomaterials.2016.02.02710.1016/j.biomaterials.2016.02.027 ↗
33. 10.1021/jacs.5b0143510.1021/jacs.5b01435 ↗
34. 10.1002/prp2.14910.1002/prp2.149 ↗
35. 10.1021/nn503431x10.1021/nn503431x ↗
36. 10.1016/j.biomaterials.2017.09.02710.1016/j.biomaterials.2017.09.027 ↗
37. 10.1002/anie.20100004410.1002/anie.201000044 ↗
38. 10.1021/jf901610h10.1021/jf901610h ↗
39. 10.1038/nnano.2014.20810.1038/nnano.2014.208 ↗
40. 10.1021/jf010897z10.1021/jf010897z ↗
41. 10.1016/j.jconrel.2012.05.04210.1016/j.jconrel.2012.05.042 ↗
42. 10.1039/c4ob02512a10.1039/c4ob02512a ↗
43. 10.1038/ncomms436410.1038/ncomms4364 ↗
44. 10.1021/acs.nanolett.7b0203110.1021/acs.nanolett.7b02031 ↗
45. 10.1002/anie.20120336010.1002/anie.201203360 ↗
46. 10.1371/journal.ppat.100051610.1371/journal.ppat.1000516 ↗
47. Wallach D. · Science · 2016 · 352 · aaf215410.1126/science.aaf2154 ↗
48. 10.1021/acsmacrolett.5b0054410.1021/acsmacrolett.5b00544 ↗
49. 10.1021/jacs.6b0178410.1021/jacs.6b01784 ↗
50. 10.1021/acs.nanolett.6b0426910.1021/acs.nanolett.6b04269 ↗
51. 10.1038/nrd400210.1038/nrd4002 ↗
52. 10.1021/acs.bioconjchem.6b0024010.1021/acs.bioconjchem.6b00240 ↗
53. 10.1021/nl400664510.1021/nl4006645 ↗
54. 10.1016/j.biomaterials.2014.04.10610.1016/j.biomaterials.2014.04.106 ↗
55. 10.1002/adma.20140449810.1002/adma.201404498 ↗
56. 10.1002/ceat.20110048410.1002/ceat.201100484 ↗
57. 10.1126/science.aaf684610.1126/science.aaf6846 ↗
58. 10.1016/s0304-3835(03)00238-610.1016/s0304-3835(03)00238-6 ↗